Mirum Pharmaceuticals Ownership | Who Owns Mirum Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Mirum Pharmaceuticals Ownership Summary


Mirum Pharmaceuticals is owned by 14.10% institutional investors, 1.84% insiders, and 84.06% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 13.66% of MIRM shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.87% of its assets in Mirum Pharmaceuticals shares.

MIRM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMirum Pharmaceuticals14.10%1.84%84.06%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Frazier life sciences management6.80M13.66%$498.15M
Janus henderson group4.58M9.59%$189.48M
Blackrock funding, inc. /de3.60M7.24%$264.09M
Blackrock3.24M6.90%$110.71M
Vanguard group2.55M5.12%$186.60M
Eventide asset management2.52M5.07%$184.92M
Bvf inc/il1.50M3.01%$109.62M
State street1.35M2.71%$98.74M
Price t rowe associates inc /md/1.28M2.58%$94.08M
Novo1.26M2.54%$92.67M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Frazier life sciences management6.80M14.93%$498.15M
Boone capital management535.73K12.88%$39.27M
First turn management570.57K6.28%$41.83M
Novo1.26M5.97%$92.67M
Bvf inc/il1.50M4.44%$109.62M
Tang capital management1.24M3.49%$90.61M
Rock springs capital management lp761.13K3.26%$55.80M
Highlander partners122.98K3.14%$9.02M
Eventide asset management2.52M3.04%$184.92M
Lion point capital, lp45.00K2.80%$1.54M

Top Buyers

HolderShares% AssetsChange
Blackrock3.24M0.00%785.78K
Wellington management group llp790.69K0.01%672.12K
Fmr640.22K0.00%580.78K
Arrowstreet capital, limited partnership612.32K0.03%536.67K
Point72 asset management790.67K0.10%531.81K

Top Sellers

HolderShares% AssetsChange
Bvf inc/il1.50M4.44%-1.27M
Bioimpact capital---589.58K
Cadian capital management, lp---475.71K
Jpmorgan chase100.21K0.00%-380.07K
Checkpoint capital---362.19K

New Positions

HolderShares% AssetsChangeValue
William blair investment management313.26K0.06%313.26K$22.97M
Timessquare capital management300.65K0.32%300.65K$22.04M
Axa investment managers255.69K0.05%255.69K$18.74M
D. e. shaw157.35K0.00%157.35K$6.51M
Voleon capital management lp86.53K0.15%86.53K$6.34M

Sold Out

HolderChange
Coldstream capital management-1.00
Ifp advisors-3.00
Nelson, van denburg & campbell wealth management group-5.00
Northwestern mutual wealth management-9.00
Stephens consulting-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202599-54.59%7,010,413-87.34%140.11%58-48.21%28-64.10%
Jun 30, 20252160.47%55,383,1624.20%1110.94%110-9.84%7823.81%
Mar 31, 20252154.37%54,155,7882.17%1100.90%1215.22%656.56%
Dec 31, 20241945.43%43,660,980-17.71%910.74%109-3.54%5640.00%
Sep 30, 202418411.52%53,056,700-0.10%1110.87%11425.27%40-20.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.41M2.87%1.77K
Eventide Gilead N1.43M2.85%-
Vanguard Total Stock Mkt Idx Inv1.34M2.68%-28.37K
Eventide Healthcare & Life Sciences I1.19M2.38%108.58K
iShares Russell 2000 ETF1.05M2.08%-
Polar Capital Biotech S Inc975.00K1.95%-
MEDICAL BioHealth EUR Acc756.50K1.59%-
Janus Henderson Global Life Sciences774.99K1.57%62.59K
Janus Henderson Global Life Sciences D774.99K1.55%-3.15K
US Small-Cap Growth II Equity Comp716.26K1.45%-40.98K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 21, 2025GREY MICHAEL G-Sell$3.50M
Sep 11, 2025Brege Laura-Sell$111.93K
Sep 11, 2025Brege Laura-Sell$1.15M
Sep 12, 2025BJERKHOLT ERIC CHIEF FINANCIAL OFFICERSell$728.02K
Sep 08, 2025Ramasastry Saira-Sell-

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3-10
2025 Q2-3
2025 Q11021
2024 Q4-1

MIRM Ownership FAQ


Who Owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals shareholders are primarily institutional investors at 14.10%, followed by 1.84% insiders and 84.06% retail investors. The average institutional ownership in Mirum Pharmaceuticals's industry, Biotech Stocks , is 45.24%, which Mirum Pharmaceuticals falls below.

Who owns the most shares of Mirum Pharmaceuticals?

Mirum Pharmaceuticals’s largest shareholders are Frazier life sciences management (6.8M shares, 13.66%), Janus henderson group (4.58M shares, 9.59%), and Blackrock funding, inc. /de (3.6M shares, 7.24%). Together, they hold 30.50% of Mirum Pharmaceuticals’s total shares outstanding.

Does Blackrock own Mirum Pharmaceuticals?

Yes, BlackRock owns 6.90% of Mirum Pharmaceuticals, totaling 3.24M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 110.71M$. In the last quarter, BlackRock increased its holdings by 785.78K shares, a 32.04% change.

Who is Mirum Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Frazier life sciences management is Mirum Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 14.93% of its assets in 6.8M Mirum Pharmaceuticals shares, valued at 498.15M$.

Who is the top mutual fund holder of Mirum Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Mirum Pharmaceuticals shares, with 2.87% of its total shares outstanding invested in 1.41M Mirum Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools